News
MedPage Today on MSN17h
Wegovy Pill Under Review; FDA Lifts Obesity Trial Clinical Hold; SGLT2s and SurgeryThe FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...
Zacks Small Cap Research on MSN20h
LTRN: IND Clearance for LP-184 in TNBCLTRN A May 5th press release indicated that the FDA cleared Lantern Pharma, Inc.’s (NASDAQ:LTRN) LP-184 trial in triple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback